99 related articles for article (PubMed ID: 34261887)
21. Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers.
Lin DH; Jones CM; Compton WM; Heyward J; Losby JL; Murimi IB; Baldwin GT; Ballreich JM; Thomas DA; Bicket M; Porter L; Tierce JC; Alexander GC
JAMA Netw Open; 2018 Jun; 1(2):e180235. PubMed ID: 30646077
[TBL] [Abstract][Full Text] [Related]
22. Trends in Health Care Expenditures and Patient Out-of-Pocket Expenses in Primary Anterior Cruciate Ligament Reconstruction.
Carbone AD; Wang K; Tiao J; Chu B; Poeran J; Colvin AC; Gladstone JN; Anthony SG
Am J Sports Med; 2022 Aug; 50(10):2680-2687. PubMed ID: 35834951
[TBL] [Abstract][Full Text] [Related]
23. Frequency and Costs of Out-of-Network Bills for Outpatient Laboratory Services Among Privately Insured Patients.
Sen AP; Meiselbach MK; Wang Y; Eisenberg MD; Anderson GF
JAMA Intern Med; 2021 Jun; 181(6):834-841. PubMed ID: 33900358
[TBL] [Abstract][Full Text] [Related]
24. Repeat Annual Lung Cancer Screening After Baseline Screening Among Screen-Negative Individuals: No-Cost Coverage Is Not Enough.
Tailor TD; Bell S; Doo FX; Carlos RC
J Am Coll Radiol; 2023 Jan; 20(1):29-36. PubMed ID: 36436778
[TBL] [Abstract][Full Text] [Related]
25. Changes in Drug List Prices and Amounts Paid by Patients and Insurers.
Yang EJ; Galan E; Thombley R; Lin A; Seo J; Tseng CW; Resneck JS; Bach PB; Dudley RA
JAMA Netw Open; 2020 Dec; 3(12):e2028510. PubMed ID: 33295971
[TBL] [Abstract][Full Text] [Related]
26. The effects of patient out-of-pocket costs on insulin use among people with type 1 and type 2 diabetes with Medicare Advantage insurance-2014-2018.
McAdam-Marx C; Ruiz-Negron N; Sullivan JM; Tucker JM
Health Serv Res; 2024 Feb; 59(1):e14152. PubMed ID: 36992575
[TBL] [Abstract][Full Text] [Related]
27. Trends in Thyroid Surgery and Guideline-Concordant Care in the United States, 2007-2018.
Toumi A; DiGennaro C; Vahdat V; Jalali MS; Gazelle GS; Chhatwal J; Kelz RR; Lubitz CC
Thyroid; 2021 Jun; 31(6):941-949. PubMed ID: 33280499
[No Abstract] [Full Text] [Related]
28. Total and out-of-pocket costs of different primary management strategies in ovarian cancer.
Suidan RS; He W; Sun CC; Zhao H; Rauh-Hain JA; Fleming ND; Lu KH; Giordano SH; Meyer LA
Am J Obstet Gynecol; 2019 Aug; 221(2):136.e1-136.e9. PubMed ID: 30965052
[TBL] [Abstract][Full Text] [Related]
29. Direct medical costs of treatment in newly-diagnosed high-grade glioma among commercially insured US patients.
Jiang S; Hill K; Patel D; Waldeck AR; Botteman M; Aly A; Norden AD
J Med Econ; 2017 Dec; 20(12):1237-1243. PubMed ID: 28777020
[TBL] [Abstract][Full Text] [Related]
30. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
Luo J; Seeger JD; Donneyong M; Gagne JJ; Avorn J; Kesselheim AS
JAMA Intern Med; 2016 Sep; 176(9):1317-23. PubMed ID: 27367749
[TBL] [Abstract][Full Text] [Related]
31. The Economic Burden of Out-of-Pocket Expenses for Plastic Surgery Procedures.
Billig JI; Chen JS; Lu YT; Chung KC; Sears ED
Plast Reconstr Surg; 2020 Jun; 145(6):1541-1551. PubMed ID: 32459783
[TBL] [Abstract][Full Text] [Related]
32. Association of High-Deductible Health Plan Enrollment With Spending on and Use of Lenalidomide Therapy Among Commercially Insured Patients With Multiple Myeloma.
Jazowski SA; Wilson L; Dusetzina SB; Zafar SY; Zullig LL
JAMA Netw Open; 2022 Jun; 5(6):e2215720. PubMed ID: 35671056
[TBL] [Abstract][Full Text] [Related]
33. Use and Costs for Tumor Gene Expression Profiling Panels in the Management of Breast Cancer From 2006 to 2012: Implications for Genomic Test Adoption Among Private Payers.
Roberts MC; Dusetzina SB
J Oncol Pract; 2015 Jul; 11(4):273-7. PubMed ID: 26105668
[TBL] [Abstract][Full Text] [Related]
34. Treatment patterns, healthcare resource utilization, and costs in patients with acute myeloid leukemia in commercially insured and Medicare populations.
Stein EM; Bonifacio G; Latremouille-Viau D; Guerin A; Shi S; Gagnon-Sanschagrin P; Briggs O; Joseph GJ
J Med Econ; 2018 Jun; 21(6):556-563. PubMed ID: 29304724
[TBL] [Abstract][Full Text] [Related]
35. Specialty drug and health care utilization vary by wage level in employer-sponsored health plans.
Sherman BW; Sils B; Kamin L; Westrich K
J Manag Care Spec Pharm; 2022 Aug; 28(8):918-928. PubMed ID: 35722830
[No Abstract] [Full Text] [Related]
36. Price Transparency in Radiology: Challenges and Opportunities to Improve.
Sadigh G; Carlos RC
AJR Am J Roentgenol; 2021 Nov; 217(5):1243-1244. PubMed ID: 34009001
[TBL] [Abstract][Full Text] [Related]
37. Healthcare costs for abortions performed in ambulatory surgery centers vs office-based settings.
Leslie DL; Liu G; Jones BS; Roberts SCM
Am J Obstet Gynecol; 2020 Apr; 222(4):348.e1-348.e9. PubMed ID: 31629727
[TBL] [Abstract][Full Text] [Related]
38. Clinical Characteristics, Health Care Utilization and Costs Among Men with Primary or Secondary Hypogonadism in a US Commercially Insured Population.
Grabner M; Bodhani A; Khandelwal N; Palli S; Bonine N; Khera M
J Sex Med; 2017 Jan; 14(1):88-97. PubMed ID: 27939338
[TBL] [Abstract][Full Text] [Related]
39. Open vs. Minimally Invasive Hysterectomy: Commercially Insured Costs and Readmissions.
Fitch K; Huh W; Bochner A
Manag Care; 2016 Aug; 25(8):40-47. PubMed ID: 28121585
[TBL] [Abstract][Full Text] [Related]
40. Impact of Insurance Provider on Overall Costs in Failed Back Surgery Syndrome: A Cost Study of 122,827 Patients.
Elsamadicy AA; Farber SH; Yang S; Hussaini SMQ; Murphy KR; Sergesketter A; Suryadevara CM; Pagadala P; Parente B; Xie J; Lad SP
Neuromodulation; 2017 Jun; 20(4):354-360. PubMed ID: 28322477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
